2019 - 2022 Pathological role of vacuolar-type proton ATPase in lysosomal disease
2018 - 2019 ヒトiPS細胞由来心筋細胞における、V-ATPase の機能的役割の解明
Show all
Papers (11):
Hirofumi Morihara, Shunichi Yokoe, Shigeo Wakabayashi, Shinji Takai. TMEM182 inhibits myocardial differentiation of human iPS cells by maintaining the activated state of Wnt/β-catenin signaling through an increase in ILK expression. FASEB BioAdvances. 2024. 6. 11. 565-579
Natsuko Morita, Hirofumi Morihara, Kazumasa Moriwaki, Atsushi Daimon, Michio Asahi, Masahide Ohmichi. Intravenous Injection of iPS Cell-Derived Endothelial Progenitor Cells Prevents Miscarriage by Releasing Pro-Angiogenic Factors in a Mouse Model of Recurrent Spontaneous Abortion. Bulletin of Osaka Medical and Pharmaceutical University. 2023. 69. 1-2. 21-30
Mahito Matsuno, Shunichi Yokoe, Takehiro Nagatsuka, Hirofumi Morihara, Kazumasa Moriwaki, Michio Asahi. O-GlcNAcylation-induced GSK-3β activation deteriorates pressure overload-induced heart failure via lack of compensatory cardiac hypertrophy in mice. Frontiers in Endocrinology. 2023. 14
TMEM182 maintains the activated state of Wnt/β-catenin signaling by increasing ILK and inhibits cardiac differentiation in human iPS cells
(The 96th Annual Meeting of the Japanese Pharmacological Society 2022)
Effect of TMEM182, a novel membrane protein, on muscle differentiation
(The 95th Annual Meeting of the Japanese Pharmacological Society 2022)
Lysosomal Regulation of mTOR-AKT Signaling via the Vacuolar-type H+- ATPase
(The 93rd Annual Meeting of the Japanese Pharmacological Society 2020)